Clear Search sequence regions


  • algorithms (2)
  • benchmark (1)
  • drug- target (10)
  • humans (1)
  • layers (1)
  • learn (3)
  • phase (1)
  • research (1)
  • Sizes of these terms reflect their relevance to your search.

    Studying drug-target interactions (DTIs) is the foundational and crucial phase in drug discovery. Biochemical experiments, while being the most reliable method for determining drug-target affinity (DTA), are time-consuming and costly, making it challenging to meet the current demands for swift and efficient drug development. Consequently, computational DTA prediction methods have emerged as indispensable tools for this research. In this article, we propose a novel deep learning algorithm named GRA-DTA, for DTA prediction. Specifically, we introduce Bidirectional Gated Recurrent Unit (BiGRU) combined with a soft attention mechanism to learn target representations. We employ Graph Sample and Aggregate (GraphSAGE) to learn drug representation, especially to distinguish the different features of drug and target representations and their dimensional contributions. We merge drug and target representations by an attention neural network (ANN) to learn drug-target pair representations, which are fed into fully connected layers to yield predictive DTA. The experimental results showed that GRA-DTA achieved mean squared error of 0.142 and 0.225 and concordance index reached 0.897 and 0.890 on the benchmark datasets KIBA and Davis, respectively, surpassing the most state-of-the-art DTA prediction algorithms.

    Citation

    Xin Tang, Xiujuan Lei, Yuchen Zhang. Prediction of Drug-Target Affinity Using Attention Neural Network. International journal of molecular sciences. 2024 May 08;25(10)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38791165

    View Full Text